{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:18:04Z","timestamp":1791249484538,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007271","name":"Health Science Center, University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.bbrc.2014.04.046","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T11:09:31Z","timestamp":1397819371000},"page":"616-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity"],"prefix":"10.1016","volume":"447","author":[{"given":"Michael J.","family":"Herr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia M.","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Homayouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Speich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash","family":"Kotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.04.046_b0005","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1182\/blood.V100.13.4502","article-title":"Identification of CD9 extracellular domains important in regulation of CHO cell adhesion to fibronectin and fibronectin pericellular matrix assembly","volume":"100","author":"Cook","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.04.046_b0010","doi-asserted-by":"crossref","first-page":"e67766","DOI":"10.1371\/journal.pone.0067766","article-title":"Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9","volume":"8","author":"Herr","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.04.046_b0015","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.yexcr.2008.01.024","article-title":"Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway","volume":"314","author":"Kotha","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2014.04.046_b0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/BST0390563","article-title":"Tetraspanin CD9 in cell migration","volume":"39","author":"Powner","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2014.04.046_b0025","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1016\/S0021-9258(18)99271-9","article-title":"CDNA cloning and expression of platelet p24\/CD9. Evidence for a new family of multiple membrane-spanning proteins","volume":"266","author":"Lanza","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.046_b0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2008.07.036","article-title":"Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasia","volume":"203","author":"Kotha","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2014.04.046_b0035","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/ijc.22902","article-title":"The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells","volume":"121","author":"Ovalle","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.04.046_b0040","doi-asserted-by":"crossref","first-page":"24092","DOI":"10.1074\/jbc.270.41.24092","article-title":"Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation","volume":"270","author":"Shaw","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.046_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.20532","article-title":"Prospects: histone deacetylase inhibitors","volume":"96","author":"Dokmanovic","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2014.04.046_b0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2014.04.046_b0055","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2014.04.046_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001813-200201000-00001","article-title":"Histone deacetylase inhibitors in cancer treatment","volume":"13","author":"Vigushin","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bbrc.2014.04.046_b0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-230X(04)91004-4","article-title":"Histone deacetylase inhibitors","volume":"91","author":"Marks","year":"2004","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbrc.2014.04.046_b0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","article-title":"Class II histone deacetylases: versatile regulators","volume":"19","author":"Verdin","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbrc.2014.04.046_b0075","first-page":"856","article-title":"Quercetin and trichostatin A cooperatively kill human leukemia cells","volume":"60","author":"Chen","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.bbrc.2014.04.046_b0080","first-page":"2791","article-title":"Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells","volume":"32","author":"Jasek","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2014.04.046_b0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-291X(02)00523-5","article-title":"Histone deacetylase inhibition results in decreased macrophage CD9 expression","volume":"294","author":"Wang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.04.046_b0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mc.20580","article-title":"Expression and function of CD9 in melanoma cells","volume":"49","author":"Fan","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbrc.2014.04.046_b0095","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.leu.2403822","article-title":"Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation","volume":"19","author":"Barrena","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2014.04.046_b0100","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1055\/s-0038-1649981","article-title":"Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity","volume":"74","author":"Jennings","year":"1995","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbrc.2014.04.046_b0105","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1016\/S0021-9258(19)39667-X","article-title":"The activation of human platelets mediated by anti-human platelet p24\/CD9 monoclonal antibodies","volume":"265","author":"Jennings","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.046_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2249.1998.00670.x","article-title":"Pattern of expression of tetraspanin antigen genes in Burkitt lymphoma cell lines","volume":"113","author":"Ferrer","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbrc.2014.04.046_b0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1745-7254.2005.00081.x","article-title":"Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation","volume":"26","author":"Liu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2014.04.046_b0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1523-1755.2003.00758.x","article-title":"Induction of DNA synthesis by ligation of the CD53 tetraspanin antigen in primary cultures of mesangial cells","volume":"63","author":"Yunta","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2014.04.046_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13402-012-0119-z","article-title":"CD81 is a candidate tumor suppressor gene in human gastric cancer","volume":"36","author":"Yoo","year":"2013","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbrc.2014.04.046_b0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.onc.1206106","article-title":"Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer","volume":"22","author":"Funakoshi","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.04.046_b0135","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2165\/11315680-000000000-00000","article-title":"Histone deacetylase inhibitors: current status and overview of recent clinical trials","volume":"69","author":"Ma","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2014.04.046_b0140","doi-asserted-by":"crossref","first-page":"34940","DOI":"10.1074\/jbc.274.49.34940","article-title":"Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects","volume":"274","author":"Sambucetti","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.046_b0145","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1091\/mbc.11.6.2069","article-title":"Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells","volume":"11","author":"Qiu","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2014.04.046_b0150","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbrc.2006.06.196","article-title":"Involvement of HDAC1 and the PI3K\/PKC signaling pathways in NF-kappaB activation by the HDAC inhibitor apicidin","volume":"347","author":"Kim","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:08:01Z","timestamp":1757761681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14006871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0006291X14006871"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.046","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}